Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Laura, Testa"'
Autor:
Renata Colombo Bonadio, Isadora Martins de Sousa, Flávia Cavalcanti Balint, Ana Carolina Marin Comini, Monique Celeste Tavares, Fernanda Madasi, Jose Bines, Rafael Dal Ponte Ferreira, Daniela Dornelles Rosa, Candice Lima Santos, Zenaide Silva de Souza, Daniele Assad-Suzuki, Júlio Antônio Pereira de Araújo, Débora de Melo Gagliato, Carlos Henrique dos Anjos, Bruna M. Zucchetti, Anezka Ferrari, Mayana Lopes de Brito, Renata Cangussu, Maria Marcela Fernandes Monteiro, Paulo M. Hoff, Laura Testa, Romualdo Barroso-Sousa
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Neoadjuvant pembrolizumab plus chemotherapy (P + CT) has emerged as a standard of care for stage II-III triple-negative breast cancer (TNBC). However, the best anthracycline-cyclophosphamide (AC) schedule remains to be determined. While the
Externí odkaz:
https://doaj.org/article/0b54a4ca94524373b724e7eccf37965d
Autor:
Matthew P. Goetz, Irfan Cicin, Laura Testa, Sara M. Tolaney, Jens Huober, Valentina Guarneri, Stephen R. D. Johnston, Miguel Martin, Priya Rastogi, Nadia Harbeck, Ashwin Shahir, Ran Wei, Valérie André, Hope S. Rugo, Joyce O’Shaughnessy
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract In monarchE, adjuvant abemaciclib significantly improved invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS), with sustained benefit beyond the 2-year treatment period. Abemaciclib dose reductions were allowed to p
Externí odkaz:
https://doaj.org/article/1378a75d34cd4a89ad1255e30c08bb59
Autor:
Felippe Lazar Neto, Marina Acevedo Zarzar de Melo, Cassio Murilo Trovo Hidalgo Filho, Maria Cecília Mathias-Machado, Laura Testa, Alessandro Gonçalves Campolina
Publikováno v:
Breast, Vol 75, Iss , Pp 103727- (2024)
Background: Breast cancer (BC) is the most incident tumor and, consequently, any new intervention can potentially promote a considerable budget impact if incorporated. Cost-effectiveness (CE) studies assist in the decision-making process but may be i
Externí odkaz:
https://doaj.org/article/7b3f36ffaf7b4d54ac5837fb95ce8385
Autor:
Javier Cortes, Eric P Winer, Oleg Lipatov, Seock‐Ah Im, Anthony Gonçalves, Eva Muñoz‐Couselo, Keun Seok Lee, Peter Schmid, Kenji Tamura, Laura Testa, Isabell Witzel, Shoichiro Ohtani, Stephanie Hund, Karina Kulangara, Vassiliki Karantza, Jaime A Mejia, Junshui Ma, Petar Jelinic, Lingkang Huang, Scott K Pruitt, Kenneth Emancipator
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 3, Pp n/a-n/a (2024)
Abstract The efficacy of pembrolizumab monotherapy versus chemotherapy increased with increasing programmed death ligand 1 (PD‐L1) expression, as quantified by combined positive score (CPS; PD‐L1 expression on both tumour cells and immune cells)
Externí odkaz:
https://doaj.org/article/42c035448af94e8fbfc51bd921ef67f3
Autor:
Aditya Bardia, Lajos Pusztai, Kathy Albain, Eva Maria Ciruelos, Seock-Ah Im, Dawn Hershman, Kevin Kalinsky, Claudine Isaacs, Delphine Loirat, Laura Testa, Eriko Tokunaga, Jiong Wu, Hannah Dry, William Barlow, Robert Kozarski, Micah Maxwell, Nadia Harbeck, Priyanka Sharma
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Despite advances in the treatment of early triple-negative breast cancer (TNBC), patients with residual invasive disease after neoadjuvant therapy have a high risk of disease recurrence and worse survival outcomes than those who have path
Externí odkaz:
https://doaj.org/article/3a1692a37ed9422f9c0bef0fb4017984
Autor:
Vanessa Petry, Renata Colombo Bonadio, Laura Testa, Daniela JBH. Cohn, Allyne Cagnacci, Roberta G. Campos, Maria Cândida Bv Fragoso, Maria del Pilar Estevez-Diz
Publikováno v:
Breast, Vol 68, Iss , Pp 157-162 (2023)
Introduction: Breast cancer (BC) is the most common type of cancer in premenopausal women with germline TP53 pathogenic variants (mTP53) (Li Fraumeni syndrome - LFS). However, little is known about the BC prognosis in these patients. This study analy
Externí odkaz:
https://doaj.org/article/cdef4509e6994b6dbb82e64eb368a096
Autor:
Leandro Jonata Carvalho Oliveira, Thais Baccili Cury Megid, Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Daniele Xavier Assad, Daniel Fontes Argolo, Solange Moraes Sanches, Laura Testa, José Bines, Rafael Kaliks, Maira Caleffi, Debora de Melo Gagliato, Marina Sahade, Romualdo Barroso-Sousa, Tatiana Strava Corrêa, Andrea Kazumi Shimada, Daniel Negrini Batista, Daniel Musse Gomes, Marcelle Goldner Cesca, Débora Gaudêncio, Larissa Matos Almeida Moura, Julio Antonio Pereira de Araújo, Artur Katz, Max Senna Mano
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Oncotype DX (ODX) is a validated assay for the prediction of risk of recurrence and benefit of chemotherapy (CT) in both node negative (N0) and 1–3 positive nodes (N1), hormone receptor positive (HR+), human epidermal growth factor rece
Externí odkaz:
https://doaj.org/article/bf12e41b48ea42f997e8e48720fed3f0
Autor:
Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Sergio D. Simon, Gilberto Amorim, Tomás Reinert, Luciana Landeiro, Débora de Melo Gagliato, Pedro Exman, Daniel Argolo, Gisah Guilgen, Max Mano, Laura Testa, Pedro Liedke, Romualdo Barroso, Mariana Sasse, Anna Maria Buehler
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Introduction: The MONALEESA-7 trial compared ribociclib plus endocrine therapy (ET) with placebo as first-line treatment of advanced luminal/HER2-negative breast cancer (ABC) in premenopausal and perimenopausal women (age
Externí odkaz:
https://doaj.org/article/e0b0a8ad353547b5a61531c64ff7af17
Autor:
Ludhmila Abrahão Hajjar, Isabela Bispo Santos da Silva da Costa, Marcelo Antônio Cartaxo Queiroga Lopes, Paulo Marcelo Gehm Hoff, Maria Del Pilar Estevez Diz, Silvia Moulin Ribeiro Fonseca, Cristina Salvadori Bittar, Marília Harumi Higuchi dos Santos Rehder, Stephanie Itala Rizk, Dirceu Rodrigues Almeida, Gustavo dos Santos Fernandes, Luís Beck-da-Silva, Carlos Augusto Homem de Magalhães Campos, Marcelo Westerlund Montera, Sílvia Marinho Martins Alves, Júlia Tizue Fukushima, Maria Verônica Câmara dos Santos, Carlos Eduardo Negrão, Thiago Liguori Feliciano da Silva, Silvia Moreira Ayub Ferreira, Marcus Vinicius Bolivar Malachias, Maria da Consolação Vieira Moreira, Manuel Maria Ramos Valente Neto, Veronica Cristina Quiroga Fonseca, Maria Carolina Feres de Almeida Soeiro, Juliana Barbosa Sobral Alves, Carolina Maria Pinto Domingues Carvalho Silva, João Sbano, Ricardo Pavanello, Ibraim Masciarelli F. Pinto, Antônio Felipe Simão, Marianna Deway Andrade Dracoulakis, Ana Oliveira Hoff, Bruna Morhy Borges Leal Assunção, Yana Novis, Laura Testa, Aristóteles Comte de Alencar Filho, Cecília Beatriz Bittencourt Viana Cruz, Juliana Pereira, Diego Ribeiro Garcia, Cesar Higa Nomura, Carlos Eduardo Rochitte, Ariane Vieira Scarlatelli Macedo, Patricia Tavares Felipe Marcatti, Wilson Mathias Junior, Evanius Garcia Wiermann, Renata do Val, Helano Freitas, Anelisa Coutinho, Clarissa Maria de Cerqueira Mathias, Fernando Meton de Alencar Camara Vieira, André Deeke Sasse, Vanderson Rocha, José Antônio Franchini Ramires, Roberto Kalil Filho
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 115, Iss 5, Pp 1006-1043 (2020)
Externí odkaz:
https://doaj.org/article/e8fe218837804dc891aecf7bf368b2ef
Autor:
Lucas Tokio Kawahara, Isabela Bispo Santos da Silva Costa, Cecília Chie Sakaguchi Barros, Gabriel Coelho de Almeida, Cristina Salvadori Bittar, Stephanie Itala Rizk, Laura Testa, Camila Motta Venchiarutti Moniz, Juliana Pereira, Gláucia Maria Moraes de Oliveira, Maria Del Pilar Estevez Diz, Patricia Oliveira Guimarães, Ibraim Masciarelli Pinto, Roberto Kalil Filho, Ludhmila Abrahão Hajjar, Paulo M. Hoff
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 115, Iss 3, Pp 547-557 (2020)
Resumo O desafio imposto ao sistema de saúde pela pandemia da COVID-19 faz com que haja uma necessidade de readequações de rotinas e serviços de saúde, com os objetivos de controlar a disseminação do vírus e preservar a saúde. Torna-se ainda
Externí odkaz:
https://doaj.org/article/9bc58ffd5fc24ee0ab5ef8c849fc733d